{"title":"Biochemical and patient factors as predictors for multiple surgeries in diabetic foot disease","authors":"Danuksha K Amarasena, Ahmad Bilal, Ibrahim H Elkhidir, Michael Flatman, Anand Pillai","doi":"10.1002/pdi.2493","DOIUrl":null,"url":null,"abstract":"Diabetic foot disease (DFD) bestows a huge surgical burden on patients and health care systems worldwide. Medical and surgical management centres around limb preservation and maintaining patient mobility. Despite vast experience in managing DFD, little is understood about the surgical prognosis of a patient presenting for their first DFD procedure.We evaluated for predictive factors, observable at a patient's first presentation for a surgical procedure on their diabetic foot, which may indicate an increased likelihood of requiring similar procedures in the future.Method: Our study included 70 patients with diabetes mellitus who underwent surgery on their diabetic foot. These patients were split into cohorts. Cohort 1 received only one surgery on their diabetic foot; Cohort 2 received multiple surgeries on their diabetic foot. Statistical analysis was conducted looking at various parameters between the cohorts to assess for any significant differences at the time of first surgery.Results: On Mann‐Whitney U test, there was a significant difference in C‐reactive protein (CRP) between patients who had a single surgery and those receiving multiple surgeries (p=0.009). A binomial logistic regression model found CRP to be a significant predictor of whether a patient will undergo one surgery or multiple surgeries (Exp[B] 0.988, 95% CI 0.978–0.998). On analysis of the ROC curve, 84mg/L was the best cut‐off for CRP in predicting number of surgeries.Clinical relevance: These predictive factors could highlight patients who are ‘at risk’ for needing further procedures, so they can be managed with more intense surveillance and follow‐up. Copyright © 2024 John Wiley & Sons.","PeriodicalId":0,"journal":{"name":"","volume":"161 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pdi.2493","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
预测糖尿病足病多次手术的生化因素和患者因素
糖尿病足病(DFD)给全球患者和医疗系统带来了巨大的手术负担。医疗和手术管理的核心是保护肢体和保持患者的活动能力。我们评估了患者首次接受糖尿病足外科手术时可观察到的预测因素,这些因素可能预示着今后需要类似手术的可能性增加:我们的研究包括 70 名接受糖尿病足手术的糖尿病患者。这些患者被分为不同的组群。组群 1 只接受了一次糖尿病足手术;组群 2 接受了多次糖尿病足手术。我们对组群间的各种参数进行了统计分析,以评估首次手术时是否存在显著差异:经曼-惠特尼 U 检验,接受过一次手术和多次手术的患者之间的 C 反应蛋白(CRP)存在显著差异(P=0.009)。二项式逻辑回归模型发现,CRP 是预测患者接受一次手术还是多次手术的重要指标(Exp[B] 0.988,95% CI 0.978-0.998)。根据 ROC 曲线分析,84 毫克/升是 CRP 预测手术次数的最佳临界值:临床相关性:这些预测因素可突出显示需要进一步手术的 "高危 "患者,以便对他们进行更严格的监控和随访。版权所有 © 2024 约翰威利父子公司。
本文章由计算机程序翻译,如有差异,请以英文原文为准。